BedSharkPal

joined 1 year ago
[–] BedSharkPal@lemmy.ca 1 points 3 days ago

I stopped watching years ago because it was becoming too close to reality for me.

[–] BedSharkPal@lemmy.ca 7 points 3 days ago

You joke, but the sciences is one of my only places to find hope.

[–] BedSharkPal@lemmy.ca 9 points 5 days ago

Ya love to see it!

[–] BedSharkPal@lemmy.ca 2 points 2 weeks ago

Toxicity drives engagement. Engagement means more ad views.

As long as profits are the motive it's a flawed design.

[–] BedSharkPal@lemmy.ca 12 points 3 weeks ago (1 children)

The actual fuck? That's disgusting.

[–] BedSharkPal@lemmy.ca 153 points 1 month ago (17 children)

You really have to wonder where the breaking point is at this point.

[–] BedSharkPal@lemmy.ca 4 points 1 month ago

The sciences are really my last bastion of hope these days. I'm constantly amazed at the rate of discovery these days and how they at least show a glimmer of hope for the future.

[–] BedSharkPal@lemmy.ca 5 points 1 month ago (5 children)
[–] BedSharkPal@lemmy.ca 222 points 1 month ago (20 children)

Ain't this guy pro Trump? I'm starting to think Elon might be some sort of idiot...

[–] BedSharkPal@lemmy.ca 2 points 1 month ago

Just save your meatballs for OF I guess.

People are into that right?

[–] BedSharkPal@lemmy.ca -1 points 1 month ago

To be fair I don't see any long range munitions on that list

[–] BedSharkPal@lemmy.ca 65 points 1 month ago (13 children)

Now I'm sitting here on the toilet wondering how many otters I could take on...

 

Patients were followed for a median of 15 months. The mean duration of B-cell aplasia was 112 ± 47 days. The researchers found that all patients with SLE had DORIS remission, all patients with idiopathic inflammatory myositis had an ACR-EULAR major clinical response, and a reduction in the score on the EUSTAR activity index was seen for all patients with systemic sclerosis. In all patients, immunosuppressive therapy was completely stopped. In 10 patients, grade 1 cytokine release syndrome occurred.

"Even though it is premature to judge whether these patients are indeed cured from their autoimmune disease, CD19 CAR T-cells at least appear to be able to achieve sustained disease- and drug-free remission," the authors write.

view more: next ›